Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-national Phase III Clinical Study Comparing NK105 Versus Paclitaxel in Patients With Metastatic or Recurrent Breast Cancer

NCT01644890 is registered in ClinicalTrials.gov with Nippon Kayaku Co., Ltd. as lead sponsor.

NCT NCT01644890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01644890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-national Phase III Clinical Study Comparing NK105 Versus Paclitaxel in Patients With Metastatic or Recurrent Breast Cancer
Lead sponsor
Nippon Kayaku Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2012
Completion date
January 31, 2017
Enrollment
436 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer nos metastatic recurrent